SL

Summitry LLC Portfolio holdings

AUM $3.04B Turnover 34.47%
1-Year Est. Return 17.05%
This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+17.05%
3 Year Est. Return
+68.13%
5 Year Est. Return
+77.78%
10 Year Est. Return
+281.24%
AUM
$1.36B
AUM Growth
+$35.1M
Cap. Flow
-$49.4M
Cap. Flow %
-3.63%
Top 10 Hldgs %
39.96%
Holding
102
New
4
Increased
33
Reduced
50
Closed
6
Avg Time Held
3.2 years
Top 10 Avg Time Held
2.3 years
Top 20 Avg Time Held
2.9 years

Top Buys

Rank Stock Value
1
MCO icon
Moody's
MCO
+$23.4M
2
KMX icon
CarMax
KMX
+$21.3M
3
AMZN icon
Amazon
AMZN
+$17.7M
4
ZBRA icon
Zebra Technologies
ZBRA
+$8.33M
5
STIP icon
iShares 0-5 Year TIPS Bond ETF
STIP
+$1.84M

Top Sells

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$39.4M
2
LOW icon
Lowe's Companies
LOW
+$21.2M
3
ROST icon
Ross Stores
ROST
+$16.8M
4
ULTA icon
Ulta Beauty
ULTA
+$16.1M
5
SBUX icon
Starbucks
SBUX
+$12.7M

Sector Composition

Rank Sector Weight
1 Financials 21.26%
2 Consumer Discretionary 18.81%
3 Technology 18.24%
4 Miscellaneous 15.76%
5 Communication Services 13.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NVS icon
101
Novartis
NVS
$279B
– –
-34,393
Closed -$2.61M –
TSLA icon
102
Tesla
TSLA
$1.45T
– –
-1,014
Closed -$269K –

Similar funds

Summitry LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Summitry LLC held 102 positions worth $1.36B, up 2.6% from $1.32B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Summitry LLC withdrew a net $49.4M in Q4 2022, closing 6 positions and reducing 50 holdings. Its most notable exit was Novartis, an estimated $2.61M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Summitry LLC opened a new position in Moody's worth $23.8M.

  • Summitry LLC's largest Q4 2022 buy was Moody's: 85,412 shares worth $23.8M.
  • Summitry LLC added most to CarMax in Q4 2022, an estimated $21.3M increase.
  • Summitry LLC's biggest Q4 2022 reduction was Northrop Grumman, cutting an estimated $39.4M.
  • Summitry LLC fully exited Novartis in Q4 2022, selling an estimated $2.61M.
  • Summitry LLC's ten largest holdings make up 40% of its $1.36B portfolio in Q4 2022.
  • Summitry LLC opened 4 new positions and closed 6 in Q4 2022.
  • Summitry LLC's portfolio value rose 2.6% quarter-over-quarter to $1.36B.

Based on Summitry LLC's 13F filing for Q4 2022, filed 10 Feb 2023.